Next 10 |
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
2024-04-24 17:20:27 ET More on Edwards Lifesciences Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained) Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript BofA upgrades Edwards to buy, says double-digit growth is ...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877...
2024-04-15 10:00:02 ET Shagun Singh from RBC Capital issued a price target of $101.00 for EW on 2024-04-15 08:08:00. The adjusted price target was set to $101.00. At the time of the announcement, EW was trading at $90.28. The overall price target consensus is at $111.78 ...
2024-04-13 09:10:00 ET Summary Wedgewood Partners is a money manager founded in 1988 with the goal of providing investors with a superior approach to managing investment portfolios. The year 2024 is off to a near-historic start with the S&P 500 Index gaining +10.5% during the ...
2024-04-11 12:17:00 ET More on Consumer Staples XLP: Expensive With Underperformance Risk XLP: Rotate Into This Lagging Sector These are the most crowded longs within consumer staples - UBS Top buy-rated stocks in consumer staples - Citi Read the fu...
2024-04-11 08:00:08 ET Anthony Petrone from Mizuho Securities issued a price target of $105.00 for EW on 2024-04-11 07:00:00. The adjusted price target was set to $105.00. At the time of the announcement, EW was trading at $91.51. The overall price target consensus is at...
2024-04-10 14:56:07 ET More on Markets OKE and F: The only 5% dividend stocks within the S&P 500 that are beating the index YTD 10-year yield tops 4.5% after strong CPI report Chances of June rate cut narrow after hot CPI print CPI inflation stays hot in ...
Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members of the National Football League (NFL) Alumni Association and their families. The findings of this study, which identified a s...
2024-03-30 12:13:00 ET The Health Care Select Sector SPDR Fund ETF ( NYSEARCA: XLV ), tracking the healthcare companies under S&P 500, rose 8.32% in the first quarter of 2024, lagging slightly behind the broader S&P 500 index which rose 10.16%.... Read the full article...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results. To participate in the conference call, dial (877...
2024-04-15 10:00:02 ET Shagun Singh from RBC Capital issued a price target of $101.00 for EW on 2024-04-15 08:08:00. The adjusted price target was set to $101.00. At the time of the announcement, EW was trading at $90.28. The overall price target consensus is at $111.78 ...